Euclidean Capital LLC 23and Me Holding Co. Call Options Transaction History
Euclidean Capital LLC
- $795 Million
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ME
# of Institutions
153Shares Held
100MCall Options Held
270KPut Options Held
349K-
New View Capital Partners I, LLC Burlingame, CA19.5MShares$96.1 Million18.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.4MShares$76.2 Million0.0% of portfolio
-
Sapphire Ventures, L.L.C. Austin, TX5.29MShares$26.1 Million1.76% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.94MShares$24.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.66MShares$23 Million0.0% of portfolio
About 23andMe Holding Co.
- Ticker ME
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 259,768,000
- Market Cap $1.28B
- Description
- 23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...